POZEN Announces October 28, 2009 Webcast of Third Quarter 2009 Results

• Press Release
• Source: POZEN Inc.
• On 7:30 am EDT, Wednesday October 14, 2009

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN - News), announced today that it will release third quarter 2009 results on October 28, 2009, before the market opens.

Related Quotes

Symbol	Price	Change
POZN	6.95	0.00

{"s" : "pozn","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The announcement will be followed by a live webcast at 11:00 a.m. Eastern Time with a discussion by POZEN management of the earnings and business results. The webcast can be accessed on POZEN’s website at www.pozen.com and will be archived and available for replay. The third quarter 2009 earnings release will be accessible in the News section of POZEN’s website.

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN’s efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for Treximet^®, which was approved in 2008 by the United States Food and Drug Administration for the acute treatment of migraine attacks, with or without aura, in adults, and with AstraZeneca for VIMOVO™, the proposed trade name for the proprietary fixed dose combination of naproxen with the proton pump inhibitor esomeprazole magnesium in a single tablet for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The Company’s common stock is traded on The NASDAQ Stock Market under the symbol “POZN”. For detailed company information, including copies of this and other press releases, see POZEN’s website: www.pozen.com.

POZEN Inc.
Bill Hodges, Chief Financial Officer
919-913-1030